In today’s highly competitive clinical research landscape, selecting the right investigators is more critical than ever. High physician turnover and growing competition have made it increasingly challenging to maintain successful clinical trial programs. Investigators play a pivotal role in patient recruitment and retention, making strategic and informed investigator selection crucial for ensuring robust study outcomes. 

View Anju’s recorded webinar to explore how a data-driven approach can revolutionize your investigator selection process. By evaluating investigators based on scientific contributions, clinical experience, and proven track records, you can make informed decisions that directly impact the success of your trials.

This recording will delve into real-world examples, demonstrating how life sciences organizations can leverage data from research publications, clinical trial databases, and professional networks to identify the ideal investigator profiles for oncology, CNS, and rare disease studies.

What You’ll Learn: 

• The Power of Data: Discover how a data-driven methodology can enhance your investigator selection process, ensuring your clinical trials are set up for success. 

• Creating the Ideal Investigator Profile: Learn how to identify investigators with the right expertise for your specific clinical study, particularly in oncology, CNS, and rare diseases. 

• Real-World Applications: Gain insights from practical use cases and examples of how data has been used to improve investigator selection and drive better clinical trial outcomes. 

Whether you’re a seasoned clinical operations professional or new to strategic feasibility planning, this session will equip you with the insights and tools to design trials that succeed in today’s competitive landscape. Don’t let your trial fall victim to the big bad wolf—join us and build it with bricks! |

Meet the Experts:  Our webinar was led by Elke Ydens and Barbara Argibay, industry veterans with extensive experience in clinical research and investigator selection. They shared their insights and guided the user through the best practices for leveraging data to improve clinical research programs.